Role of S protein transmembrane domain mutations in the development of occult hepatitis B virus infection

References

• Raimondo G, Locarnini S, Pollicino T, et al. Update of the statements on biology and clinical impact of occult hepatitis B virus infection. J Hepatol. 2019 Aug;71(2):397–408.
   PubMed Web of Science ®Google Scholar
• Liu GC, Sui GY, Liu GY, et al. A Bayesian meta-analysis on prevalence of hepatitis B virus infection among Chinese volunteer blood donors. PloS one. 2013;8(11):e79203.
   PubMed Web of Science ®Google Scholar
• Kwak MS, Kim YJ. Occult hepatitis B virus infection. World J Hepatol. 2014 Dec 27;6(12):860–869.
   PubMedGoogle Scholar
• Candotti D, Boizeau L, Laperche S. Occult hepatitis B infection and transfusion–transmission risk. Transfus Clin Biol. 2017 Sep;24(3):189–195.
   PubMed Web of Science ®Google Scholar
• Coffin CS, Mulrooney-Cousins PM, van Marle G, et al. Hepatitis B virus quasispecies in hepatic and extrahepatic viral reservoirs in liver transplant recipients on prophylactic therapy. Liver Transplant: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society. 2011 Aug;17(8):955–962.
   PubMed Web of Science ®Google Scholar
• Zhou S, Li T, Allain JP, et al. Low occurrence of HBsAg but high frequency of transient occult HBV infection in vaccinated and HBIG-administered infants born to HBsAg positive mothers. J Med Virol. 2017 Dec;89(12):2130–2137.
   PubMed Web of Science ®Google Scholar
• Kumar R, Pérez-Del-Pulgar S, Testoni B, et al. Clinical relevance of the study of hepatitis B virus covalently closed circular DNA. Liver Int: Official Journal of the International Association for the Study of the Liver. 2016 Jan;36(Suppl 1):72–77.
   PubMedGoogle Scholar
• Pollicino T, Raimondo G. Occult hepatitis B infection. J Hepatol. 2014 Sep;61(3):688–689.
   PubMed Web of Science ®Google Scholar
• Mak LY, Wong DK, Pollicino T, et al. Occult hepatitis B infection and hepatocellular carcinoma: epidemiology, virology, hepatocarcinogenesis and clinical significance. J Hepatol. 2020 Oct;73(4):952–964.
   PubMed Web of Science ®Google Scholar
• Wang H, Wang M, Huang J, et al. Novel hepatitis B virus surface antigen mutations associated with occult genotype B hepatitis B virus infection affect HBsAg detection. J Viral Hepat. 2020 Sep;27(9):915–921.
   PubMed Web of Science ®Google Scholar
• Wang J, Liu Y, Liao H, et al. The sK122R mutation of hepatitis B virus (HBV) is associated with occult HBV infection: analysis of a large cohort of Chinese patients. J Clin Virol. 2020 Sep;130:104564.
   PubMed Web of Science ®Google Scholar
• Liao H, Liu Y, Chen J, et al. Characterization of hepatitis B virus (HBV) preS/S gene mutations in blood donors with occult HBV infection in the Baoji area of North China. Transfusion. 2017 Mar;57(3pt2):857–866.
   PubMedGoogle Scholar
• Martin CM, Welge JA, Rouster SD, et al. Mutations associated with occult hepatitis B virus infection result in decreased surface antigen expression in vitro. J Viral Hepat. 2012 Oct;19(10):716–723.
   PubMed Web of Science ®Google Scholar
• Wu C, Deng W, Deng L, et al. Amino acid substitutions at positions 122 and 145 of hepatitis B virus surface antigen (HBsAg) determine the antigenicity and immunogenicity of HBsAg and influence in vivo HBsAg clearance. J Virol. 2012 Apr;86(8):4658–4669.
   PubMed Web of Science ®Google Scholar
• Chen J, Liu B, Tang X, et al. Role of core protein mutations in the development of occult HBV infection. J Hepatol. 2021 Jun;74(6):1303–1314.
   PubMed Web of Science ®Google Scholar
• Stirk HJ, Thornton JM, Howard CR. A topological model for hepatitis B surface antigen. Intervirology. 1992;33(3):148–158.
   PubMed Web of Science ®Google Scholar
• Nassal M, Rieger A, Steinau O. Topological analysis of the hepatitis B virus core particle by cysteine-cysteine cross-linking. J Mol Biol. 1992 Jun 20;225(4):1013–1025.
   PubMed Web of Science ®Google Scholar
• Zhang L, Chang L, Laperche S, et al. Occult HBV infection in Chinese blood donors: role of N-glycosylation mutations and amino acid substitutions in S protein transmembrane domains. Emerg Microbes Infect. 2019;8(1):1337–1346.
   PubMed Web of Science ®Google Scholar
• Jiang X, Chang L, Yan Y, et al. Paradoxical HBsAg and anti-HBs coexistence among chronic HBV infections: causes and consequences. Int J Biol Sci. 2021;17(4):1125–1137.
   PubMed Web of Science ®Google Scholar
• Wang J, Jia J, Chen R, et al. RFX1 participates in doxorubicin-induced hepatitis B virus reactivation. Cancer Med. 2018 May;7(5):2021–2033.
   PubMed Web of Science ®Google Scholar
• Awerkiew S, Däumer M, Reiser M, et al. Reactivation of an occult hepatitis B virus escape mutant in an anti-HBs positive, anti-HBc negative lymphoma patient. J Clin Virol. 2007 Jan;38(1):83–86.
   PubMed Web of Science ®Google Scholar
• Pollicino T, Raffa G, Costantino L, et al. Molecular and functional analysis of occult hepatitis B virus isolates from patients with hepatocellular carcinoma. Hepatology. 2007 Feb;45(2):277–285.
   PubMed Web of Science ®Google Scholar
• Svicher V, Cento V, Bernassola M, et al. Novel HBsAg markers tightly correlate with occult HBV infection and strongly affect HBsAg detection. Antiviral Res. 2012 Jan;93(1):86–93.
   PubMed Web of Science ®Google Scholar
• Hosseini SY, Sanaei N, Fattahi MR, et al. Association of HBsAg mutation patterns with hepatitis B infection outcome: asymptomatic carriers versus HCC/cirrhotic patients. Ann Hepatol. 2019 Jul-Aug;18(4):640–645.
   PubMed Web of Science ®Google Scholar
• Weinberger KM, Bauer T, Böhm S, et al. High genetic variability of the group-specific a-determinant of hepatitis B virus surface antigen (HBsAg) and the corresponding fragment of the viral polymerase in chronic virus carriers lacking detectable HBsAg in serum. J Gen Virol. 2000 May;81(Pt 5):1165–1174.
   PubMedGoogle Scholar
• Ye X, Li T, Shao W, et al. Nearly half of Ultrio plus NAT non-discriminated reactive blood donors were identified as occult HBV infection in South China. BMC Infect Dis. 2019 Jul 3;19(1):574.
   PubMedGoogle Scholar
• Biswas S, Candotti D, Allain J-P. Specific amino acid substitutions in the S protein prevent its excretion in vitro and may contribute to occult hepatitis B virus infection. J Virol. 2013 July;87(14):7882–7892.
   PubMed Web of Science ®Google Scholar
• Kim KH, Chang HY, Park JY, et al. Spontaneous HBsAg loss in Korean patients: relevance of viral genotypes, S gene mutations, and covalently closed circular DNA copy numbers. Clin Mol Hepatol. 2014 Sep;20(3):251–260.
   PubMedGoogle Scholar